175 related articles for article (PubMed ID: 22811352)
1. The characteristics of ABO antibodies in group O Thai blood donors.
Khampanon K; Chanprakop T; Sriwanitchrak P; Setthakarn M; Oota S; Nathalang O
J Clin Lab Anal; 2012 Jul; 26(4):223-6. PubMed ID: 22811352
[TBL] [Abstract][Full Text] [Related]
2. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.
Josephson CD; Mullis NC; Van Demark C; Hillyer CD
Transfusion; 2004 Jun; 44(6):805-8. PubMed ID: 15157243
[TBL] [Abstract][Full Text] [Related]
3. High titers of anti-A1 and anti-B antibodies among Peruvian group O platelet donors.
Aguilar G; Ortiz N; Gonzales D; Loyola S; Paredes JA
Transfus Apher Sci; 2022 Jun; 61(3):103341. PubMed ID: 34916156
[TBL] [Abstract][Full Text] [Related]
4. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch.
De Santis GC; Garcia-Silva AC; Dotoli GM; de Castro PT; Simões BP; Covas DT
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28160319
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anti-A and anti-B hemolysis among blood group O donors in Lagos.
Oyedeji OA; Adeyemo TA; Ogbenna AA; Akanmu AS
Niger J Clin Pract; 2015; 18(3):328-32. PubMed ID: 25772913
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ABO antibody titration, IgG subclasses and qualitative haemolysin test to reduce the risk of passive haemolysis associated with platelet transfusion.
Bastos EP; Castilho L; Bub CB; Kutner JM
Transfus Med; 2020 Aug; 30(4):317-323. PubMed ID: 32484285
[TBL] [Abstract][Full Text] [Related]
7. Differences in ABO antibody levels among blood donors: a comparison between past and present Japanese, Laotian, and Thai populations.
Mazda T; Yabe R; NaThalang O; Thammavong T; Tadokoro K
Immunohematology; 2007; 23(1):38-41. PubMed ID: 17425414
[TBL] [Abstract][Full Text] [Related]
8. [Anti-A/B Antibody Titers in Group O Healthy Donors in Hainan Province Area].
Yu S; Huang YW; Wang XX; Wu YQ; Lin MX; Yu Y; Luo Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1138-43. PubMed ID: 26314460
[TBL] [Abstract][Full Text] [Related]
9. Complement activating ABO anti-A IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible transfusions.
Pandey P; Anani WQ; Pugh T; Gottschall JL; Denomme GA
J Transl Med; 2020 May; 18(1):216. PubMed ID: 32466782
[TBL] [Abstract][Full Text] [Related]
10. Increased but stable isoagglutinin titers in hemodialysis patients.
Assing K; Sprogoe U; Nielsen C; Rasmussen M; Yazer M; Bistrup C
J Nephrol; 2019 Feb; 32(1):121-127. PubMed ID: 30066253
[TBL] [Abstract][Full Text] [Related]
11. Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.
Pagano MB; Katchatag BL; Khoobyari S; Van Gerwen M; Sen N; Rebecca Haley N; Gernsheimer TB; Hess JR; Metcalf RA
Transfusion; 2019 Apr; 59(4):1246-1251. PubMed ID: 30592057
[TBL] [Abstract][Full Text] [Related]
12. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
13. No increase in anti-A isohemagglutinin titer after SARS-CoV-2 infection: A retrospective cohort analysis of group O apheresis platelet donors.
Wasiluk T; Bujno M; Rybinska K; Rogowska A; Zebrowska A; Boczkowska-Radziwon B; Piszcz J; Bolkun L; Radziwon P
J Clin Apher; 2021 Dec; 36(6):882-885. PubMed ID: 34590725
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility Analysis of Establishing Combat Readiness Blood Bank Based on Low Titer Group O Whole Blood and Group A Plasma].
Luo YY; Ma CY; Liu L; Fu LH; Yi M; Yu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):541-545. PubMed ID: 38660864
[TBL] [Abstract][Full Text] [Related]
15. Effect of ABO mismatching on a radioimmunoassay for platelet compatibility. Successful adsorption of ABO alloantibodies with synthetic A and B substance.
Ellinger PJ; Morgan LK; Malecek AC; Chaplin H
Transfusion; 1989 Feb; 29(2):134-8. PubMed ID: 2645695
[TBL] [Abstract][Full Text] [Related]
16. Anti-A and anti-B haemolysins, dangerous universal blood donors and the risk of ABO antagonism in a Nigerian community.
Okafor LA; Enebe S
Trop Geogr Med; 1985 Sep; 37(3):270-2. PubMed ID: 4071650
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Magnetized-Erythrocyte Group Antigens to Detect ABO Antibodies.
Nathalang O; Intharanut K; Sriwanitchrak P; Setthakarn M; Duan S; Wang H; Ding S; Li Y
Indian J Hematol Blood Transfus; 2016 Dec; 32(4):442-446. PubMed ID: 27812254
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
[TBL] [Abstract][Full Text] [Related]
19. Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method.
Stussi G; Huggel K; Lutz HU; Schanz U; Rieben R; Seebach JD
Br J Haematol; 2005 Sep; 130(6):954-63. PubMed ID: 16156865
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of ABO A2 kidneys into O recipients: do IgM anti-A1 titers matter?
Tierney J; Shaffer D
Clin Transplant; 2015 Apr; 29(4):379-82. PubMed ID: 25659826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
